| | | | | Product | Package Size | EFP | CP | SB | DC | Composition | Registr. Holder | Category | | | | |
---|
What is an ATC-Code? | ATC-Overview |
|
| | IP | CI | | Ampho-Moronal | 20 Tablet(s) | 11.20 | 28.60 | 10 % | | Tablets: Amphotericinum B 100 mg | Dermapharm AG | B / SL | FB | | G |  |
| | IP | CI | | Ampho-Moronal | 24 ml | 8.68 | 25.85 | 10 % | | Suspension zur Anwendung in der Mundhöhle/zum Einnehmen: Amphotericinum B 100 mg/ml | Dermapharm AG | B / SL | FB | | G |  |
|
L | | IP | CI | PP | Dificlir | 20 Tablet(s) | 1582.19 | 1737.15 | 10 % | | Coated tablets: Fidaxomicinum 200 mg | Tillotts Pharma AG | A / SL | FB | | G |  |
|
| | IP | CI | Ph | Arkocaps charbon végétal | 45 | PR | PR | k.A. | | Capsules: Carbo Activatus 225 mg | Arko Diffusion AG | D | FB | | G |  |
| | IP | CI | | Norit | 30 Capsule(s) | PR | PR | k.A. | | Capsules: Carbo Activatus 200 mg | APS-Arzneimittel- Parallelimport- Service AG | D | FB | | G |  |
| | IP | CI | PhCM | Phytopharma Charbon végétal | 30 Capsule(s) | PR | PR | k.A. | | Capsules: Carbo Activatus 225 mg | Arko Diffusion AG | D | FB | | G |  |
| | | CI | | Carbovit | 100 ml | PR | PR | k.A. | | Suspension (oral): Carbo Activatus 15 g | Cyntos AG | D | FB | | G |  |
|
| | IP | CI | | Carboticon | 30 x 2 Capsule(s) | 6.79 | 12.55 | k.A. | | Capsules: 2 Active Agents Capsules: 2 Active Agents Capsules: 2 Active Agents | Leman SKL SA | D | FB | | G |  |
| | IP | CI | | Carbolevure | 20 Capsule(s) | PR | 12.15 | k.A. | | Kapseln für Erwachsene: 2 Active Agents | Pierre Fabre Pharma SA | D | FB | | G |  |
| | IP | CI | | Carbolevure | 30 Capsule(s) | PR | 16.45 | k.A. | | Kapseln für Erwachsene: 2 Active Agents | Pierre Fabre Pharma SA | D | FB | | G |  |
| | IP | CI | | Carbolevure | 20 Capsule(s) | PR | 9.85 | k.A. | | Kapseln für Kinder: 2 Active Agents | Pierre Fabre Pharma SA | ● D | FB | | G |  |
|
| | IP | CI | | Elotrans | 20 Sachet(s) | 4.58 | 8.45 | 10 % | | Soluble Powder: 4 Active Agents | Helvepharm AG | D / SL | FB | | G |  |
| | IP | CI | | Oralpädon Erdbeere | 10 | PR | PR | k.A. | | Pulver zur Herstellung einer Lösung zum Einnehmen: 2 Active Agents | Spirig HealthCare AG | D | FB | | G |  |
| | IP | CI | | Normolytoral | 10 Sachet(s) | 4.37 | 8.05 | k.A. | | Pulver zur Herstellung einer Lösung zum Einnehmen im Beutel: 4 Active Agents | Gebro Pharma AG | D | FB | | G |  |
|
| | IP | CI | | Loperamid lingual Spirig HC | 20 | 3.48 | 6.45 | 10 % | | Melting tablets: Loperamidi Hydrochloridum 2 mg | Spirig HealthCare AG | D / SL / SG | FB | | G |  |
| | IP | CI | | Loperamid lingual Spirig HC | 60 | 7.93 | 25.10 | 10 % | | Melting tablets: Loperamidi Hydrochloridum 2 mg | Spirig HealthCare AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Loperam-X lingual | 20 | PR | PR | k.A. | | Melting tablets: Loperamidi Hydrochloridum 2 mg | axapharm ag | D | FB | | G |  |
| | IP | CI | | Imodium ‐ I - T | 20 Capsule(s) | 3.87 | 6.85 | 20 % | | Capsules: Loperamidi Hydrochloridum 2 mg | JNTL Consumer Health II (Switzerland) GmbH | D / SL / SO | FB | | G |  |
| | IP | CI | | Imodium - T | 60 Capsule(s) | 9.40 | 26.60 | 20 % | | Capsules: Loperamidi Hydrochloridum 2 mg | JNTL Consumer Health II (Switzerland) GmbH | B / SL / SO | FB | | G |  |
| | IP | CI | | Loperamid Streuli 2 mg | 20 Capsule(s) | 3.48 | 6.45 | 10 % | | Loperamidi Hydrochloridum 2 mg | Streuli Pharma AG | ● D / SL / SG | FB | | G |  |
| | IP | CI | | Loperamid Streuli 2 mg | 60 Capsule(s) | 8.59 | 25.75 | 10 % | | Loperamidi Hydrochloridum 2 mg | Streuli Pharma AG | B / SL / SG | FB | | G |  |
| | IP | CI | CM | Loperamid Spirig HC 2 mg | 20 Tablet(s) | 3.48 | 6.45 | 10 % | | Coated tablets: Loperamidi Hydrochloridum 2 mg | Spirig HealthCare AG | D / SL / SG | FB | | G |  |
| | IP | CI | CM | Loperamid Spirig HC 2 mg | 60 Tablet(s) | 7.93 | 25.10 | 10 % | | Coated tablets: Loperamidi Hydrochloridum 2 mg | Spirig HealthCare AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Loperamid-Mepha 2 ‐ I | 20 Tablet(s) | 3.48 | 6.45 | 10 % | | Coated tablets: Loperamidi Hydrochloridum 2 mg | Mepha Pharma AG | D / SL / SG | FB | | G |  |
| | IP | CI | | Loperamid-Mepha 2 ‐ I | 60 Tablet(s) | 7.88 | 25.00 | 10 % | | Coated tablets: Loperamidi Hydrochloridum 2 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
| | IP | CI | CM | Loperamid Sandoz | 20 Capsule(s) | 3.48 | 6.45 | 10 % | | Capsules: Loperamidi Hydrochloridum 2 mg | Sandoz Pharmaceuticals AG | ● D / SL / SG | FB | | G |  |
| | IP | CI | CM | Loperamid Sandoz | 60 Capsule(s) | 8.59 | 25.75 | 10 % | | Capsules: Loperamidi Hydrochloridum 2 mg | Sandoz Pharmaceuticals AG | ● B / SL / SG | FB | | G |  |
| | IP | CI | CM | Loperamid Zentiva 2 mg | 20 | 3.48 | 6.45 | 10 % | | Capsules: Loperamidi Hydrochloridum 2 mg | Helvepharm AG | D / SL / SG | FB | | G |  |
| | IP | CI | CM | Loperamid Zentiva 2 mg | 60 | 9.58 | 26.75 | 10 % | | Capsules: Loperamidi Hydrochloridum 2 mg | Helvepharm AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Imodium lingual - T | 20 Tablet(s) | 8.05 | 15.50 | k.A. | | Melting tablets: Loperamidi Hydrochloridum 2 mg | JNTL Consumer Health II (Switzerland) GmbH | D | FB | | G |  |
| | IP | CI | | Imodium lingual akut | 10 | PR | PR | k.A. | | Melting tablets: Loperamidi Hydrochloridum 2 mg | JNTL Consumer Health II (Switzerland) GmbH | D | FB | | G |  |
| | IP | CI | | Imodium lingual akut | 12 | PR | PR | k.A. | | Melting tablets: Loperamidi Hydrochloridum 2 mg | JNTL Consumer Health II (Switzerland) GmbH | D | FB | | G |  |
| | IP | CI | | Loperamid-Mepha lingual 2 mg | 20 | PR | PR | k.A. | | Melting tablets: Loperamidi Hydrochloridum 2 mg | Mepha Pharma AG | D | FB | | G |  |
| | IP | CI | CM | Amavita Loperamid 2 mg | 20 Capsule(s) | PR | PR | k.A. | | Capsules: Loperamidi Hydrochloridum 2 mg | Amavita Health Care AG | D | FB | | G |  |
| | IP | CI | CM | SUN STORE Loperamid 2 mg | 20 | PR | PR | k.A. | | Capsules: Loperamidi Hydrochloridum 2 mg | Sun Store Health Care AG | D | FB | | G |  |
| | IP | CI | | Lopimed | 20 Capsule(s) | 5.23 | 9.65 | k.A. | | Capsules: Loperamidi Hydrochloridum 2 mg | Sandoz Pharmaceuticals AG | C | FB | | G |  |
| | IP | CI | | Lopimed | 60 Capsule(s) | 12.15 | 26.20 | k.A. | | Capsules: Loperamidi Hydrochloridum 2 mg | Sandoz Pharmaceuticals AG | B | FB | | G |  |
|
| | IP | CI | | Imodium duo | 8 Tablet(s) | PR | PR | k.A. | | Tablets: 2 Active Agents | JNTL Consumer Health II (Switzerland) GmbH | D | FB | | G |  |
| | IP | CI | | Imodium duo | 12 | PR | PR | k.A. | | Tablets: 2 Active Agents | JNTL Consumer Health II (Switzerland) GmbH | D | FB | | G |  |
|
| | IP | CI | | Budesonid Spirig HC 3 mg | 20 | 11.08 | 28.45 | 10 % | | Hartkapsel mit veränderter Wirkstofffreisetzung: Budesonidum 3 mg | Spirig HealthCare AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Budesonid Spirig HC 3 mg | 50 | 27.54 | 46.35 | 10 % | | Hartkapsel mit veränderter Wirkstofffreisetzung: Budesonidum 3 mg | Spirig HealthCare AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Budesonid Spirig HC 3 mg | 100 | 53.68 | 74.80 | 10 % | | Hartkapsel mit veränderter Wirkstofffreisetzung: Budesonidum 3 mg | Spirig HealthCare AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Budenofalk 4 mg | 12 | 75.19 | 98.20 | 10 % | | Zäpfchen: Budesonidum 4 mg | Dr. Falk Pharma AG | B / SL | FB | | G |  |
| | IP | CI | | Budenofalk 4 mg | 60 | 323.32 | 368.05 | 10 % | | Zäpfchen: Budesonidum 4 mg | Dr. Falk Pharma AG | B / SL | FB | | G |  |
| | IP | CI | | Entocort CIR 3 mg | 20 Capsule(s) | 19.11 | 36.70 | 10 % | | Hartkapsel mit veränderter Wirkstofffreisetzung: Budesonidum 3 mg | Tillotts Pharma AG | B / SL / SO | FB | | G |  |
| | IP | CI | | Entocort CIR 3 mg | 50 Capsule(s) | 47.76 | 67.10 | 10 % | | Hartkapsel mit veränderter Wirkstofffreisetzung: Budesonidum 3 mg | Tillotts Pharma AG | B / SL / SO | FB | | G |  |
| | IP | CI | | Entocort CIR 3 mg | 100 Capsule(s) | 95.39 | 117.60 | 10 % | | Hartkapsel mit veränderter Wirkstofffreisetzung: Budesonidum 3 mg | Tillotts Pharma AG | B / SL / SO | FB | | G |  |
| | IP | CI | | Budenofalk 2 mg | 14 piece(s) | 79.18 | 102.55 | 10 % | | | Dr. Falk Pharma AG | B / SL | FB | | G |  |
| | IP | CI | | Budenofalk 2 mg | 2 x 14 piece(s) | 146.76 | 176.05 | 10 % | | | Dr. Falk Pharma AG | B / SL | FB | | G |  |
L | | IP | CI | | Entocort Enema | Kombipackung(en) | 40.89 | 60.90 | 10 % | | Enema: Budesonidum 2.3 mg Enema: Budesonidum 2mg / 100ml | Tillotts Pharma AG | ● B / SL | FB | | G |  |
L | | IP | CI | | Jorveza 1 mg | 20 | 79.78 | 103.20 | 10 % | | Melting tablets: Budesonidum 1 mg | Dr. Falk Pharma AG | ● B / SL | FB | | G |  |
L | | IP | CI | | Jorveza 1 mg | 60 | 239.35 | 276.70 | 10 % | | Melting tablets: Budesonidum 1 mg | Dr. Falk Pharma AG | B / SL | FB | | G |  |
L | | IP | CI | | Cortiment MMX 9mg | 30 | 86.47 | 110.45 | 10 % | | Delayed release tablets: Budesonidum 9 mg | Ferring AG | B / SL | FB | | G |  |
| | IP | CI | | Budenofalk 3 mg | 50 Capsule(s) | 49.70 | 69.10 | 10 % | | Capsules: Budesonidum 3 mg | Dr. Falk Pharma AG | B / SL | FB | | G |  |
| | IP | CI | | Budenofalk 3 mg | 100 Capsule(s) | 93.62 | 115.75 | 10 % | | Capsules: Budesonidum 3 mg | Dr. Falk Pharma AG | B / SL | FB | | G |  |
L | | IP | | | Jorveza 0.5 mg | 20 | 72.43 | 95.20 | 10 % | | Schmeltabletten: Budesonidum | Dr. Falk Pharma AG | B / SL | FB | | G |  |
L | | IP | | | Jorveza 0.5 mg | 90 | 325.94 | 370.90 | 10 % | | Schmeltabletten: Budesonidum | Dr. Falk Pharma AG | B / SL | FB | | G |  |
| | IP | CI | | Budenofalk Uno 9 mg | 20 Sachet(s) | 60.39 | 82.10 | 10 % | | magensaftresistentes Granulat: Budesonidum 9 mg | Dr. Falk Pharma AG | B / SL | FB | | G |  |
| | IP | CI | | Budenofalk Uno 9 mg | 60 Sachet(s) | 180.62 | 212.85 | 10 % | | magensaftresistentes Granulat: Budesonidum 9 mg | Dr. Falk Pharma AG | B / SL | FB | | G |  |
| | | | | Budesonid-Mepha, Hartkapsel mit veränderter Wirkstofffreisetzung 3mg | 50 | PR | PR | k.A. | | Budesonidum 3 mg | Mepha Pharma AG | B | FB | | G |  |
| | | | | Budesonid-Mepha, Hartkapsel mit veränderter Wirkstofffreisetzung 3mg | 100 | PR | PR | k.A. | | Budesonidum 3 mg | Mepha Pharma AG | B | FB | | G |  |
| | | | | Budesonid-Mepha, Hartkapsel mit veränderter Wirkstofffreisetzung 3mg | 100 | PR | PR | k.A. | | Budesonidum 3 mg | Mepha Pharma AG | B | FB | | G |  |
|
L | | IP | CI | | Salofalk 500 | 20 suppositories | 14.46 | 32.05 | 10 % | | Suppositories: Mesalazinum 500 mg | Dr. Falk Pharma AG | B / SL / SO | FB | | G |  |
L | | IP | CI | | Salofalk 500 | 50 suppositories | 30.41 | 49.25 | 10 % | | Suppositories: Mesalazinum 500 mg | Dr. Falk Pharma AG | B / SL / SO | FB | | G |  |
L | | IP | CI | | Salofalk 1 g | 10 suppositories | 21.70 | 39.85 | 10 % | | Suppositories: Mesalazinum 1000 mg | Dr. Falk Pharma AG | B / SL / SO | FB | | G |  |
L | | IP | CI | | Salofalk 1 g | 30 suppositories | 65.10 | 86.75 | 10 % | | Suppositories: Mesalazinum 1000 mg | Dr. Falk Pharma AG | B / SL / SO | FB | | G |  |
L | | IP | CI | | Salofalk 1 g | 60 suppositories | 114.57 | 140.20 | 10 % | | Suppositories: Mesalazinum 1000 mg | Dr. Falk Pharma AG | B / SL / SO | FB | | G |  |
L | | IP | CI | | Yaldigo 500 mg | 20 | 12.79 | 30.35 | 10 % | | Suppositories: Mesalazinum | Tillotts Pharma AG | B / SL / SG | FB | | G |  |
L | | IP | CI | | Yaldigo 500 mg | 50 | 26.91 | 45.70 | 10 % | | Suppositories: Mesalazinum | Tillotts Pharma AG | B / SL / SG | FB | | G |  |
L | | IP | CI | | Yaldigo 1 g | 10 | 19.20 | 37.30 | 10 % | | Suppositories: Mesalazinum 1 g | Tillotts Pharma AG | B / SL / SG | FB | | G |  |
L | | IP | CI | | Yaldigo 1 g | 30 | 57.60 | 79.05 | 10 % | | Suppositories: Mesalazinum 1 g | Tillotts Pharma AG | B / SL / SG | FB | | G |  |
L | | IP | CI | | Yaldigo 1 g | 60 | 101.38 | 126.65 | 10 % | | Suppositories: Mesalazinum 1 g | Tillotts Pharma AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Mezavant, 1,2 g magensaftresistente Retardtabletten | 60 | 47.32 | 67.90 | 10 % | | Mesalazinum 1.2 g | Takeda Pharma AG | B / SL | FB | | G |  |
| | IP | CI | | Pentasa Klysma | 7 Enema(s) | 17.99 | 36.00 | 10 % | | | Ferring AG | B / SL | FB | | G |  |
| | IP | CI | | Salofalk 1000 mg | 14 | 28.95 | 47.90 | 10 % | | | Dr. Falk Pharma AG | B / SL | FB | | G |  |
| | IP | CI | | Salofalk 1000 mg | 50 Sachet(s) | 45.04 | 65.40 | 10 % | | Granulate: Mesalazinum 1 g | Dr. Falk Pharma AG | B / SL | FB | | G |  |
| | IP | CI | | Salofalk 1000 mg | 150 Sachet(s) | 114.86 | 141.35 | 10 % | | Granulate: Mesalazinum 1 g | Dr. Falk Pharma AG | B / SL | FB | | G |  |
| | IP | CI | | Salofalk 1.5 g | 60 Sachet(s) | 75.10 | 98.10 | 10 % | | Granulate: Mesalazinum 1.5 g | Dr. Falk Pharma AG | B / SL | FB | | G |  |
| | IP | CI | | Salofalk 3 g | 30 Sachet(s) | 78.06 | 101.30 | 10 % | | Granulate: Mesalazinum 3000 mg | Dr. Falk Pharma AG | B / SL | FB | | G |  |
| | IP | CI | | Salofalk 3 g | 90 | 199.05 | 232.90 | 10 % | | Granulate: Mesalazinum 3000 mg | Dr. Falk Pharma AG | B / SL | FB | | G |  |
L | | IP | CI | | Pentasa | 28 suppositories | 39.81 | 60.80 | 10 % | | Suppositories: Mesalazinum 1 g | Ferring AG | B / SL | FB | | G |  |
| | IP | CI | | Asacol 400 | 100 Tablet(s) | 29.01 | 47.95 | 10 % | | Coated tablets: Mesalazinum 400 mg | Medinova AG | B / SL | FB | | G |  |
| | IP | CI | | Asacol 800 | 48 Tablet(s) | 25.87 | 44.55 | 10 % | | Coated tablets: Mesalazinum 800 mg | Medinova AG | B / SL | FB | | G |  |
| | IP | CI | | Salofalk 250 | 100 Tablet(s) | 23.20 | 41.65 | 10 % | | Coated tablets: Mesalazinum 250 mg | Dr. Falk Pharma AG | B / SL | FB | | G |  |
| | IP | CI | | Salofalk 500 | 100 Tablet(s) | 38.31 | 58.10 | 10 % | | Coated tablets: Mesalazinum 500 mg | Dr. Falk Pharma AG | B / SL | FB | | G |  |
| | IP | CI | | Salofalk 1 g | 20 | 13.00 | 30.55 | 10 % | | Coated tablets: Mesalazinum 1000 mg | Dr. Falk Pharma AG | B / SL | FB | | G |  |
| | IP | CI | | Salofalk 1 g | 100 | 64.97 | 87.05 | 10 % | | Coated tablets: Mesalazinum 1000 mg | Dr. Falk Pharma AG | B / SL | FB | | G |  |
| | IP | CI | | Yaldigo 1600 mg | 60 | 60.09 | 81.75 | 10 % | | Gastric juice resistant tablets: Mesalazinum 1600 mg | Tillotts Pharma AG | B / SL | FB | | G |  |
| | IP | CI | | Pentasa 1g | 50 Sachet(s) | 36.20 | 55.80 | 10 % | | Depot-Granulat: Mesalazinum 1 g | Ferring AG | B / SL | FB | | G |  |
| | IP | CI | | Pentasa 1g | 150 Sachet(s) | 103.07 | 128.50 | 10 % | | Depot-Granulat: Mesalazinum 1 g | Ferring AG | B / SL | FB | | G |  |
| | IP | CI | | Pentasa 2g | 60 Sachet(s) | 78.21 | 101.45 | 10 % | | Depot-Granulat: Mesalazinum 2 g | Ferring AG | B / SL | FB | | G |  |
| | IP | CI | | Pentasa 500 mg | 100 Tablet(s) | 29.56 | 48.55 | 10 % | | Depot-Tabletten: Mesalazinum 500 mg | Ferring AG | B / SL | FB | | G |  |
| | IP | CI | | Pentasa 500 mg | 300 Tablet(s) | 88.01 | 112.15 | 10 % | | Depot-Tabletten: Mesalazinum 500 mg | Ferring AG | B / SL | FB | | G |  |
| | IP | CI | | Pentasa 1g | 60 Tablet(s) | 28.86 | 47.80 | 10 % | | Depot-Tabletten: Mesalazinum 1 g | Ferring AG | B / SL | FB | | G |  |
| | IP | CI | | Salofalk 2 g | 7 Enema(s) | 22.15 | 40.50 | 10 % | | lavements: Mesalazinum 2 g | Dr. Falk Pharma AG | B / SL | FB | | G |  |
| | IP | CI | | Salofalk 4 g | 7 Enema(s) | 35.41 | 54.95 | 10 % | | lavements: Mesalazinum 4 g | Dr. Falk Pharma AG | B / SL | FB | | G |  |
| | IP | CI | | Salofalk 250 | 30 suppositories | PR | PR | k.A. | | Suppositories: Mesalazinum 250 mg | Dr. Falk Pharma AG | B | FB | | G |  |
| | IP | CI | | Yaldigo 400 mg | 100 | PR | PR | k.A. | | Gastric juice resistant tablets: Mesalazinum 400 mg | Tillotts Pharma AG | B | FB | | G |  |
| | IP | CI | | Yaldigo 1600 mg | 30 | PR | PR | k.A. | | Gastric juice resistant tablets: Mesalazinum 1600 mg | Tillotts Pharma AG | B | FB | | G |  |
| | IP | CI | | Yaldigo 1600 mg | 90 | PR | PR | k.A. | | Gastric juice resistant tablets: Mesalazinum 1600 mg | Tillotts Pharma AG | B | FB | | G |  |
| | IP | CI | | Yaldigo 800 mg | 30 | PR | PR | k.A. | | magensaftesistente Tablette: Mesalazinum 800 mg | Tillotts Pharma AG | B | FB | | G |  |
| | IP | CI | | Yaldigo 800 mg | 90 | PR | PR | k.A. | | magensaftesistente Tablette: Mesalazinum 800 mg | Tillotts Pharma AG | B | FB | | G |  |
|
| | | CI | | Colibiogen oral | 100 ml | PR | PR | k.A. | | Solution (oral): Escherichiae coli Lysatum (Stamm Laves) 760-870 mg/ml | Laves-Arzneimittel Gesellschaft mit beschränkter Haftung, Ronnenberg, Zweigniederlassung Schötz | D | FB | | G |  |
|
| | | | | Sidroga Durchfalltee | 20 x 0.2 g | PR | PR | k.A. | | Arzneitee: Agrimoniae Herba (Agrimonia Eupatoria l., Herba) 1.5 g | Uriach Switzerland AG | E | FB | | G |  |
|
| | IP | CI | | Geli-Stop | 50 Tablet(s) | PR | 15.90 | k.A. | | Tablets: 3 Active Agents | Tentan AG | D | FB | | G |  |
|
| | | CI | H | Apo-Enterit | 10 g | PR | 10.50 | k.A. | | Globules: 4 Active Agents | ebi-pharm ag | D | FB | | G |  |
| | | CI | H | Apo-Enterit | 50 ml | PR | 15.70 | k.A. | | Drops: 4 Active Agents | ebi-pharm ag | D | FB | | G |  |
| | | CI | H | Dr. Reckeweg R 4 Enterocolin | 50 ml | PR | PR | k.A. | | gouttes buvables: 6 Active Agents | Laboratoire Jacques Reboh et fils SA | D | FB | | G |  |